Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160.90 EUR | +0.25% |
|
+2.58% | +0.31% |
May. 21 | Wolters Kluwer Introduces Ovid Guidelines AI, Transforming Clinical Guidelines Development with Agentic AI | CI |
May. 15 | Wolters Kluwer N.V. - Shareholder/Analyst Call |
Evolution of the Average Target: Wolters Kluwer N.V.
Evolution of the Target Price: Wolters Kluwer N.V.
Changes in Analyst Recommendations: Wolters Kluwer N.V.
884edffb69775038845ed6.tQa_6REUAb5CFWmsRR_klC02AFMIWl0zgbiNRR7te0s.-VL2qmZgQtsbci7rfXGu8EhxeQlPYydV99b6c0uKLjmEa9SEdCF52wR9Hg~d2cdc6b4b339f1d4e3e9cb9829e1f9b9
More recommendations
Consensus | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+2.15% | ||||||
+12.05% | ||||||
-3.99% | ||||||
+7.58% | ||||||
+3.01% | ||||||
-6.27% | ||||||
+16.84% | ||||||
-9.97% | ||||||
+6.69% | ||||||
+20.58% | ||||||
Average | +4.87% | |||||
Weighted average by Cap. | +5.23% |
Analysts' Consensus
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
160.50EUR
Average target price
163.96EUR
Spread / Average Target
+2.15%
High Price Target
180.00EUR
Spread / Highest target
+12.15%
Low Price Target
145.00EUR
Spread / Lowest Target
-9.66%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
GOLDMAN SACHS | Lisa Yang |
UBS | |
alphavalue | Alexandre Desprez |
BERNSTEIN RESEARCH | Simon Baker |
DEUTSCHE BANK RESEARCH | Silvia Cuneo |
AlphaValue/Baader Europe | |
JPMORGAN | Daniel Kerven |
BARCLAYS | Nick Dempsey |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WKL Stock
- Consensus Wolters Kluwer N.V.
Select your edition
All financial news and data tailored to specific country editions